Charles J. Casamento
Director, RespireRx Pharmaceuticals Inc.
Companies
- GT Biopharma, Inc.Board member May 4, 2023 to now1
- Eton Pharmaceuticals, Inc.Board member Nov 13, 2018 to now2
- RELMADA THERAPEUTICS, INC.Board member Jul 16, 2015 to now3
- Kuvatris Therapeutics, Inc.Board member Oct 4, 2022 to Mar 14, 20244
- GridAI Technologies Corp.Board member Mar 9, 2017 to Jan 4, 20245
- International Stem Cell CORPBoard member Jun 22, 2010 to Jun 25, 20186
- Astex PharmaceuticalsBoard member Jan 9, 2006 to Oct 16, 20137
- VivusBoard member Apr 21, 2008 to Apr 22, 20138
- RespireRx Pharmaceuticals Inc.Board member Jan 30, 2006 to Aug 7, 20129
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- GridAI Technologies Corp. GRDX19,937 shares10$91.7K at $4.60Jan 2, 2024
- RELMADA THERAPEUTICS, INC. RLMD10,000 shares11$31.6K at $3.17Oct 22, 2024
- Kuvatris Therapeutics, Inc.2,386 shares12Mar 12, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Oct 22, 2024Gift 13,000 shares of RELMADA THERAPEUTICS, INC.11
- Sep 9, 2024Bought 13,000 shares at $2.56 of RELMADA THERAPEUTICS, INC.13
- Mar 12, 2024Shares withheld for tax 992 shares at $0.69 of Kuvatris Therapeutics, Inc.12
- Jan 29, 2024Shares withheld for tax 97 shares at $0.76 of Kuvatris Therapeutics, Inc.14
- Jan 2, 2024Granted 19,633 shares of GridAI Technologies Corp.10
- Oct 2, 2023Shares withheld for tax 6,536 shares at $0.29 of Kuvatris Therapeutics, Inc.15
- Sep 15, 2023Sold 10 shares at $0.43 of GridAI Technologies Corp.16
- Aug 31, 2023Sold 6,053 shares at $0.30 of GridAI Technologies Corp.17
- Apr 13, 2023Granted 14,000 shares of Kuvatris Therapeutics, Inc.18
- Jan 3, 2023Granted 84,745 shares of GridAI Technologies Corp.19
- Oct 1, 2022Granted 51,583 shares of Kuvatris Therapeutics, Inc.20
- Apr 1, 2022Sold 3,300 shares at $29.00 of RELMADA THERAPEUTICS, INC.21
- Apr 1, 2022Sold 3,300 shares at $29.00 of RELMADA THERAPEUTICS, INC.21
- Apr 1, 2022Sold 3,300 shares at $29.00 of RELMADA THERAPEUTICS, INC.21
- Apr 1, 2022Sold 3,300 shares at $29.00 of RELMADA THERAPEUTICS, INC.21
- Apr 1, 2022Sold 3,300 shares at $29.00 of RELMADA THERAPEUTICS, INC.21
- Apr 1, 2022Sold 3,300 shares at $29.00 of RELMADA THERAPEUTICS, INC.21
- Apr 1, 2022Exercised options 19,800 shares at $3.24 of RELMADA THERAPEUTICS, INC.21
- Dec 3, 2021Gift 10,000 shares of RELMADA THERAPEUTICS, INC.22
- Dec 3, 2021Gift 10,000 shares of RELMADA THERAPEUTICS, INC.22
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARGT Biopharma, Inc., Board member
- 2
- 3
- 4
- 5
- 6
- 7SEC EDGARAstex Pharmaceuticals, Board member
- 8SEC EDGARVivus, Board member
- 9
- 10
- 11
- 12
- 13SEC EDGARForm 4 filed Sep 11, 2024
- 14SEC EDGARForm 4 filed Jan 31, 2024
- 15SEC EDGARForm 4 filed Oct 4, 2023
- 16SEC EDGARForm 4 filed Sep 18, 2023
- 17SEC EDGARForm 4 filed Sep 5, 2023
- 18SEC EDGARForm 4 filed Apr 14, 2023
- 19SEC EDGARForm 4 filed Jan 5, 2023
- 20SEC EDGARForm 4 filed Oct 4, 2022
- 21SEC EDGARForm 4 filed Apr 5, 2022
- 22SEC EDGARForm 5 filed Feb 2, 2023